H.C. Wainwright Biotech Breakthroughs: A Monthly Discovery Series with Patrick Trucchio


On February 16 at 10am ET, HCW is hosting the second key opinion leader (KOL) event in Biotech Breakthroughs, a monthly discovery series in which we intend to focus on novel technologies, modalities, and delivery mechanisms typically near key value-generating data readouts with the potential to enable new treatments across multiple disease areas.

In this second event, we are honored to host a fireside panel with Dr. Patrick Moriarty and Dr. Sascha Goonewardena to discuss the lipoprotein(a), or Lp(a), treatment landscape including Silence’s (SLN; Buy) zerlasiran, an RNA interference therapeutic candidate nearing a Phase 2 readout in the ALPACAR-360 program, as well as other compounds in clinical development including olpasiran (siRNA), pelacarsen (ASO), and lepodisiran (siRNA).

Confirm that you are registering to join the VIRTUAL Conference online


  Company Name
  First Name
  Last Name
  Email (use individual’s own unique email address)
  Mobile Number
  H.C. Wainwright Contact/Invited By
  Assistant Name
  Assistant Email

Please Note: As the in-person capacity evolves in the coming months, we will evaluate the number of clients we can host at the conference. The safety and health of our clients, service providers, and employees is always our first priority, and will remain top-of-mind as we move forward with this event.


• For Qualified Investors Attendance is FREE-OF-CHARGE.
• Registration subject to verification of credentials; we do not accept registrations from individuals or companies offering competitive services.
• Notice: H.C. Wainwright reserves the right to return/cancel any registration.
• Cancellation: If HCW cancels the Virtual Conference, HCW shall NOT be liable for any costs incurred by conference attendees.
• Date Change: The Virtual Conference schedule is tentative and subject to change without notice.

© Copyright 2021 – H.C. Wainwright & Co.
430 Park Avenue, New York, New York 10022

QUESTIONS/COMMENTS: Please contact Lily Khaykina at 212-356-0529; or email LK@hcwco.com

This communication is for informational purposes only. It is not intended as an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Since H.C. Wainwright & Co., LLC is not a tax advisor, transactions requiring tax consideration should be reviewed carefully with your tax advisor. All market prices, data and other information are not guaranteed as to completeness or accuracy and are subject to change without notice H.C. Wainwright & Co., LLC., Member FINRA, SIPC.

Privacy Policy | Business Continuity Plan | Electronic Communications | DMCA Policy | Contact Us
Member FINRA | SIPC | Rule 606 Reports | Rule 606 Reports Archive | BrokerCheck | Terms of Use | Disclosures